Company
Nalu Bio
Unlocking the ENDOCANNABINOID SYSTEM (ECS) for Healthier Living
Also known as Nalu Bio, Inc
- Status
- Operatingas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Legal name
- Nalu Bio, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
At Nalu Bio, we’re building a first-of-its-kind ECS drug discovery platform—leveraging AI and biological modeling to accelerate the development of next-generation therapeutics designed to address the growing burden of inflammatory, immune, and metabolic diseases.
Funding snapshot
- Total raised
- $4.8MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $4.8M2023-01-30
Funding rounds
- Round, 2023
- $4.8M2023-01-30, SEC form D sold, 11 investors
Products
- Other
- ECS Technology Platform
Loading relationship preview